MarketCap
Facebook
X
TelegramAnnual report 2023
added 12-27-2025
Profound Medical Corp. P/CF Ratio 2011-2026 | PROF
Annual P/CF Ratio Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -10.3 | -11.1 | -8.07 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -8.07 | -11.1 | -9.81 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
2 | $ 13.17 | 0.46 % | $ 1.78 B |  USA |
 |
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
-0.98 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M |  China |
 |
Eargo
EAR
|
-0.145 | - | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
14.5 | $ 10.8 | 4.05 % | $ 387 M | USA |
 |
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
-10.8 | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
15.3 | $ 25.6 | -0.43 % | $ 216 M | USA |
 |
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-4.42 | $ 3.47 | 4.52 % | $ 130 M |  France |
 |
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | USA |
 |
Helius Medical Technologies
HSDT
|
-0.34 | $ 2.12 | 3.92 % | $ 1.29 M | USA |
 |
Inspire Medical Systems
INSP
|
15.1 | $ 56.7 | 1.0 % | $ 1.67 B | USA |
 |
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
15 | $ 61.0 | 1.5 % | $ 3.33 B |  Britain |
 |
ClearPoint Neuro
CLPT
|
-13.2 | $ 11.37 | 1.7 % | $ 322 M | USA |
 |
Cardiovascular Systems
CSII
|
-24.2 | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-2.82 | $ 0.61 | 0.36 % | $ 38 M | USA |
 |
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | USA |
 |
Invacare Corporation
IVC
|
-0.436 | - | - | $ 24.7 M | USA |
 |
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
-7.85 | $ 1.03 | - | $ 17.4 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-25 | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
-90 | $ 15.65 | 3.92 % | $ 367 M | USA |
 |
Butterfly Network
BFLY
|
-18.4 | $ 5.4 | 12.97 % | $ 1.14 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | USA |
 |
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | USA |
 |
Sintx Technologies
SINT
|
-0.806 | $ 2.41 | 14.22 % | $ 6.68 M | USA |
 |
Globus Medical
GMED
|
16.6 | $ 91.34 | 1.29 % | $ 12.4 B | USA |
 |
TransMedics Group
TMDX
|
24.3 | $ 100.01 | -0.77 % | $ 3.4 B | USA |
 |
NanoVibronix
NAOV
|
-0.0366 | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
7.72 | $ 36.8 | 0.38 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
15.2 | $ 84.03 | -5.06 % | $ 2.92 B | USA |
 |
Stryker Corporation
SYK
|
34.6 | $ 294.73 | -6.47 % | $ 113 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
30.6 | $ 83.98 | 0.57 % | $ 49.1 B | USA |
 |
Tandem Diabetes Care
TNDM
|
-130 | $ 19.41 | -0.61 % | $ 1.32 B | USA |
 |
LENSAR
LNSR
|
-4.81 | $ 5.61 | 7.27 % | $ 67.1 M | USA |
 |
Pulmonx Corporation
LUNG
|
-2.25 | $ 1.35 | 5.47 % | $ 54.9 M | USA |
 |
MiMedx Group
MDXG
|
10.5 | $ 3.68 | 9.52 % | $ 544 M | USA |
 |
Myomo
MYO
|
-2.34 | $ 0.9 | 4.16 % | $ 37.7 M | USA |